Syndax Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. 

CEO
Michael A. Metzger
CEOMichael A. Metzger
Employees
298
Employees298
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2005
Founded2005
Employees
298
Employees298

SNDX Key Statistics

Market cap
1.56B
Market cap1.56B
Price-Earnings ratio
-6.29
Price-Earnings ratio-6.29
Dividend yield
Dividend yield
Average volume
2.17M
Average volume2.17M
High today
High today
Low today
Low today
Open price
$17.69
Open price$17.69
Volume
0.00
Volume0.00
52 Week high
$25.59
52 Week high$25.59
52 Week low
$8.59
52 Week low$8.59

Stock Snapshot

The current Syndax Pharmaceuticals(SNDX) stock price is $17.23, with a market capitalization of 1.56B. The stock trades at a price-to-earnings (P/E) ratio of -6.29.

Syndax Pharmaceuticals(SNDX) stock opened on 2026-06-11 at $17.69. The price climbed to — and dipped to —.

The Syndax Pharmaceuticals(SNDX)'s current trading volume is 0, compared to an average daily volume of 2.17M.

In the last year, Syndax Pharmaceuticals(SNDX) shares hit a 52-week high of $25.59 and a 52-week low of $8.59.

In the last year, Syndax Pharmaceuticals(SNDX) shares hit a 52-week high of $25.59 and a 52-week low of $8.59.

SNDX News

TipRanks 14h
Syndax Pharmaceuticals Reports New Significant Financial Obligation Agreement

Syndax Pharmaceuticals ( (SNDX) ) has shared an update. Syndax Pharmaceuticals filed a Current Report on Form 8-K that references information previously disclo...

TipRanks 14h
Syndax Shareholders Approve 2026 Equity and ESPP Plans

The latest announcement is out from Syndax Pharmaceuticals ( (SNDX) ). At its Annual Meeting held on June 10, 2026, Syndax Pharmaceuticals’ stockholders approv...

Simply Wall St 5d
A Look At Syndax Pharmaceuticals Valuation After Recent Share Price Weakness - simplywall.st

...

A Look At Syndax Pharmaceuticals Valuation After Recent Share Price Weakness - simplywall.st

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.